Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-15-003940

Options or other derivatives

  • VP Global Regulatory & Quality acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mitchell David Chilton · VP Global Regulatory & Quality

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-01-11 Grant or award : show line 1 in the form Stock Option (Right to Buy) +35,000 $9.51 2025-01-10 35,000 35,000 D
Loading xslF345X03/doc4.xml…